AstraZeneca Vaxx Participant Suffered Serious Neurological Disorder

AstraZeneca Vaxx Participant Suffered Serious Neurological Disorder

AstraZeneca Vaxx Participant Suffered Serious Neurological Disorder

By AS English

The global trial of the AstraZeneca-Oxford Covid-19 vaccine candidate, considered one of the more promising among the many being developed worldwide, is facing a further setback after the New York Times reported a second trial volunteer had suffered side effects from the experimental drug.

The late stage trial was put on hold earlier this month after a case of transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by viral infections, was reported in a trial participant in the UK. According to the NYT, another suspected case of transverse myelitis has now been reported. An AstraZeneca spokesperson told the US publication that in the first instance a case of undiagnosed multiple sclerosis had been detected in the first volunteer.

The second case has yet to be diagnosed but an expert consulted by the NYT said it would represent a “dangerous pattern” and that a third case could see the trial shut down indefinitely.

However, AstraZeneca published data on 11 September that the company said showed the two cases were “unlikely to be associated with the vaccine or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine.”

AstraZeneca trials still on hold in the United States

Trials of the AstraZeneca-Oxford University vaccine candidate have been restarted in the UK, Brazil, South Africa and India but remain on hold in the United States, where experts have expressed their preoccupation with a perceived lack of transparency in Covid-19 vaccine trials being carried out by various companies including AstraZeneca, Pfizer and Moderna. Public and professional concerns led all the three companies to release details of their trials in recent weeks.

There are currently 18,000 people participating in the trials worldwide and according to experts it is normal for some volunteers to show adverse effects to an experimental vaccine. However, the latest reports of a participant in the AstraZeneca trial suffering potentially the same complications as the first patient will increase pressure on the company not to rush the development of its vaccine and to increase transparency over the trials.

Original Source:

Australia Jab Injuries – Angus (28yrs, M), Brisbane, QLD, Australia

The Data Says You Should Never Breastfeed Your Baby After You’ve Been Vaccinated

An Australian Fed Up With Our State Governments Still Trying to Peddle the Covid Fraud

Australia Jab Injuries – Elle (31yrs, F), Sunshine Coast, QLD, Australia

“If Only We Had More Somalis” Said No One Ever

The Covid Pandemic Isn’t Over – Simply Because it Never Started- What Started was a Falsified Hyped Pre Planned Flu, Made Out to be a Global Pandemic, that Scammed Taxpayers Around the World for Hundreds of Billions if Not Trillions

Pfizer COVID Vaccine Approved for All Children Aged Over Six Months Old

“The Therapeutic Goods Administration (TGA) has Approved Pfizer’s Paediatric dose of its COVID Vaccine for Children Aged Between Six Months and Five Years Old”

Australia Jab Injuries – Xavier (14yrs, M), Kyneton, VIC, Australia

Europe Suffers Horrifying 755% Increase in Excess Deaths Among Children Since EMA Approved COVID Vaccine for Kids

Australia Jab Injuries – Taylor (20yrs, F), Wollongong, NSW, Australia

Top Doctor who Once Promoted COVID Vaccines on TV, Now Says they Should be Halted

Suspend All COVID-19 mRNA Vaccines Until Side-Effects are Fully Investigated, Says Leading Doctor Who Promoted Them on TV

Someone Put Out This Video of Celebrities Killed or Injured by the Jab. People Waking up Every Day!

This Is The UK’s Most Esteemed Cardiologist Who Was Originally Pro-vaccine. He Is Now Speaking Out Against The Vaccines Because They Are Causing Harm

Donate Now to Help Take Back Our World

$1000 Donation Turns Into $4000 of the New Global Currency

Enter Email to get Daily News